Cargando…

Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials

BACKGROUND: Niemann-Pick disease type C (NPC) is a lysosomal storage disease with a heterogeneous neurodegenerative clinical course. Multiple therapies are in clinical trials and inclusion criteria are currently mainly based on age and neurological signs, not taking into consideration differential i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortina-Borja, Mario, te Vruchte, Danielle, Mengel, Eugen, Amraoui, Yasmin, Imrie, Jackie, Jones, Simon A., i Dali, Christine, Fineran, Paul, Kirkegaard, Thomas, Runz, Heiko, Lachmann, Robin, Bremova-Ertl, Tatiana, Strupp, Michael, Platt, Frances M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097294/ https://www.ncbi.nlm.nih.gov/pubmed/30115089 http://dx.doi.org/10.1186/s13023-018-0880-9

Ejemplares similares

A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C
por: Bremova‐Ertl, Tatiana, et al.
Publicado: (2021)

Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators
por: Stampfer, Miriam, et al.
Publicado: (2013)

Retinal axonal degeneration in Niemann–Pick type C disease
por: Havla, Joachim, et al.
Publicado: (2020)

A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease
por: Giese, Anne-Katrin, et al.
Publicado: (2015)

Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale
por: Patterson, Marc C., et al.
Publicado: (2021)

Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective
por: Mengel, Eugen, et al.
Publicado: (2021)

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
por: Fields, T, et al.
Publicado: (2023)

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
por: Wraith, James E, et al.
Publicado: (2009)

A Suspicion Index to aid screening of early-onset Niemann-Pick disease Type C (NP-C)
por: Pineda, Mercedes, et al.
Publicado: (2016)

Consensus clinical management guidelines for Niemann-Pick disease type C
por: Geberhiwot, Tarekegn, et al.
Publicado: (2018)

Identification of novel bile acids as biomarkers for the early diagnosis of Niemann‐Pick C disease
por: Mazzacuva, Francesca, et al.
Publicado: (2016)

Plasma Lysosphingomyelin Demonstrates Great Potential as a Diagnostic Biomarker for Niemann-Pick Disease Type C in a Retrospective Study
por: Welford, Richard W. D., et al.
Publicado: (2014)

Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
por: Bremova-Ertl, Tatiana, et al.
Publicado: (2021)

Niemann-Pick disease type C symptomatology: an expert-based clinical description
por: Mengel, Eugen, et al.
Publicado: (2013)

Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
por: Mengel, Eugen, et al.
Publicado: (2020)

Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR)
por: Bolton, Shaun C., et al.
Publicado: (2022)

Immune dysfunction in Niemann‐Pick disease type C
por: Platt, Nick, et al.
Publicado: (2015)

Correction to: Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
por: Mengel, Eugen, et al.
Publicado: (2021)

Acetyl-leucine slows disease progression in lysosomal storage disorders
por: Kaya, Ecem, et al.
Publicado: (2020)

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
por: Fields, T., et al.
Publicado: (2021)

Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)
por: Geberhiwot, Tarekegn, et al.
Publicado: (2023)

NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls
por: Probert, Fay, et al.
Publicado: (2017)

Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry
por: Patterson, Marc C., et al.
Publicado: (2020)

Niemann-Pick disease type C
por: Vanier, Marie T
Publicado: (2010)

Stem Cells and Niemann Pick Disease
por: Andolina, Marino
Publicado: (2014)

Stem Cells in Niemann-Pick Disease
por: Kim, Sun-Jung, et al.
Publicado: (2008)

Niemann-Pick disease and platelet dysfunction
Publicado: (2012)

Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
por: Fineran, Paul, et al.
Publicado: (2017)

Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database
por: Imrie, Jackie, et al.
Publicado: (2015)

Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update
por: Patterson, Marc C., et al.
Publicado: (2017)

Mechanistic convergence and shared therapeutic targets in Niemann‐Pick disease
por: Colaco, Alexandria, et al.
Publicado: (2019)

Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat
por: Walterfang, Mark, et al.
Publicado: (2012)

Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease
por: Torres, Sandra, et al.
Publicado: (2017)

Niemann-Pick Disease: An Approach for Diagnosis in Adulthood
por: Patiño-Escobar, Bonell, et al.
Publicado: (2019)

The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann–Pick disease type C
por: Platt, Frances M.
Publicado: (2023)

Defective platelet function in Niemann‐Pick disease type C1
por: Chen, Oscar C. W., et al.
Publicado: (2020)

Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study
por: Patterson, Marc C, et al.
Publicado: (2015)

The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma
por: Chen, Ke-Ji, et al.
Publicado: (2018)

Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1
por: Chen, Oscar C W, et al.
Publicado: (2023)

Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteria
por: Weng, Yuzhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9imlvjojjbqnhrb2638g2dv0od